What Does Insulet Corporation Do?

Total employees3980
HeadquartersActon
Founded2000

Insulet Corporation (NASDAQ: PODD) is an innovative medical device company dedicated to making the lives of people with diabetes easier. Insulet's flagship product, the Omnipod® Insulin Management System, is a revolutionary tubeless insulin pump that provides continuous insulin delivery with just two parts: a small, waterproof Pod and a handheld Personal Diabetes Manager (PDM) or smartphone app. The company is focused on expanding access to its Omnipod platform, driving innovation in diabetes management, and improving patient outcomes globally.

Where Is Insulet Corporation's Headquarters?

HQ Function

The Acton headquarters serves as the central hub for Insulet's global operations, including research and development, corporate strategy, marketing, sales, advanced manufacturing, and administrative functions.

Notable Features:

The facility is a state-of-the-art building featuring advanced, automated high-speed manufacturing lines for Omnipod products, modern R&D laboratories, and collaborative office spaces designed to foster innovation.

Work Culture:

Insulet promotes a patient-centric work culture focused on innovation, collaboration, and a shared mission to improve the lives of individuals with diabetes. The environment encourages agility, problem-solving, and continuous improvement in a fast-paced setting.

HQ Significance:

The Acton headquarters represents Insulet's commitment to U.S.-based advanced manufacturing, innovation, and scalable growth. It centralizes key functions, enabling efficient operations and capacity to meet increasing global demand for its Omnipod System.

Values Reflected in HQ: The headquarters reflects Insulet's core values of patient-centricity, innovation, quality, and operational excellence through its advanced manufacturing capabilities, R&D focus, and collaborative workspace design.

Location:

Insulet Corporation has a significant global presence, with direct operations primarily in North America (United States and Canada) and numerous countries across Europe, including the United Kingdom, Germany, France, the Netherlands, and Nordic countries. They also reach additional international markets through a network of distributors. Globally supported functions include sales, marketing, customer care, clinical support, regulatory affairs, and distribution of the Omnipod system to a growing international patient base.

Street Address:

100 Nagog Park

City:

Acton

State/Province:

Massachusetts

Country:

USA

Where Else Does Insulet Corporation Operate Around the World?

San Diego, California, USA

Address: 9980 Huennekens St, San Diego, CA 92121, USA (Representative address for Insulet's San Diego presence; specific office details may vary)

Leverages the rich tech talent pool in Southern California to advance Insulet's digital health capabilities and enhance the user experience of its products.

London, United Kingdom

Address: One Dorset Rise, London, EC4Y 8EN, United Kingdom

Drives market expansion and adoption of the Omnipod System in the European region, tailoring strategies to diverse national healthcare systems and patient needs.

Buying Intent Signals for Insulet Corporation

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Insulet Corporation? Meet the Executive Team

As of April 2025, Insulet Corporation' leadership includes:

James (Jim) Hollingshead - President and Chief Executive Officer
Wayde McMillan - Executive Vice President, Chief Financial Officer and Treasurer
Eric Benjamin - Executive Vice President, Strategy, Business Development and Digital Health
Mark Field - Executive Vice President and Chief Technology Officer
Bret Christensen - Executive Vice President, Chief Commercial Officer
Michael Spears - Executive Vice President, Global Operations
Lauren Budden - Senior Vice President, General Counsel, Chief Compliance Officer and Secretary
Trang Ly - Senior Vice President and Medical Director

Who's Investing in Insulet Corporation?

Insulet Corporation has been backed by several prominent investors over the years, including:

The Vanguard Group, Inc.
BlackRock, Inc.
State Street Corporation
FMR LLC (Fidelity Management & Research)
Capital Research Global Investors
Wellington Management Group LLP
T. Rowe Price Associates, Inc.
Polen Capital Management
Geode Capital Management, LLC

What Leadership Changes Has Insulet Corporation Seen Recently?

Hire1
Exits1

Over the past 12 months, Insulet Corporation has seen strategic executive appointments aimed at strengthening its commercial leadership and continued operational excellence, alongside planned retirements and transitions within its senior team.

Departures

Charles (Chuck) Alpuche, Charles Alpuche retired as EVP and COO, marking the end of his tenure after contributing significantly to Insulet's operational growth.

New Appointments:

Bret Christensen, Bret Christensen joined Insulet as Executive Vice President, Chief Commercial Officer, tasked with leading the company's global commercial strategy and execution.

What Technology (Tech Stack) Is Used byInsulet Corporation?

Discover the tools Insulet Corporation uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Insulet Corporation Email Formats and Examples

Insulet Corporation typically utilizes standard corporate email formats. The most commonly observed and predicted successful format for reaching Insulet employees is the [first_initial][last]@[companydomain].com pattern.

[first_initial][last]@insulet.com

Format

jdoe@insulet.com

Example

75%

Success rate

What's the Latest News About Insulet Corporation?

Insulet Investor Relations | Business WireMay 9, 2024

Insulet Reports First Quarter 2024 Revenue Growth of 26% and Raises Full Year 2024 Guidance

Insulet Corporation announced its financial results for the first quarter ended March 31, 2024, reporting a 26% increase in revenue year-over-year. The growth was primarily driven by strong U.S. Omnipod sales, particularly the Omnipod 5 Automated Insulin Delivery System. The company also raised its full-year 2024 guidance for revenue and gross margin....more

Insulet Investor Relations | Business WireApril 24, 2024

Omnipod® 5 Further Expands Automated Insulin Delivery Choice With New Compatibility for Both Dexcom G7 and G6 CGM Systems in the U.S.

Insulet announced that its Omnipod 5 Automated Insulin Delivery System is now compatible with both the Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring (CGM) Systems in the United States. This integration offers Omnipod 5 users greater flexibility and choice in managing their diabetes....more

Insulet Investor Relations | Business WireFebruary 22, 2024

Insulet Reports Fourth Quarter and Full Year 2023 Financial Results, Exceeding Expectations and Providing Strong 2024 Outlook

Insulet Corporation announced robust financial results for the fourth quarter and full year ended December 31, 2023. The company exceeded revenue expectations, driven by the continued strong adoption of Omnipod 5, and provided an optimistic financial outlook for 2024....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Insulet Corporation, are just a search away.